Clinical Trials Browser

Central Nervous System Neoplasms × avelumab × 90 days × Clear all

NCT05081180 2026-05-01

Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors

Phase 1 Active not recruiting

Neoplasms, Central Nervous System Neoplasms